发明名称 Anticarcinogenic drug composition
摘要 <p>The invention provides an anticarcinogenic drug composition which effectively inhibits the recurrence of hepatocellular carcinoma (the occurrence of second primary tumor), the occurrence of hepatocellular carcinoma in high risk groups with chronic hepatitis and liver cirrhosis, the occurrence of cervical carcinoma intraepitheliale, lung adenocarcinoma, lung squamous cell carcinoma, mammary tumor, and the like and is highly safe. The anticarcinogenic drug composition contains 3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid or a salt thereof.</p>
申请公布号 EP0847754(A1) 申请公布日期 1998.06.17
申请号 EP19970121938 申请日期 1997.12.12
申请人 LEBER CO., LTD. 发明人 MUTO, YASUTOSHI;MORIWAKI, HISATAKA;NINOMIYA, MITSUO;ADACHI, SADASHI;SAITO, AKIKO;TAKASAKI, TAKESHI;TANAKA, T.;TSURUMI, KAITO,;OKUNO, MASATAKA;TOMITA, EIICHI;NAKAMURA, TOSHIYUKI;KOJIMA, TAKAO
分类号 A61K31/202;A61K31/19;A61P35/00;C07C57/03;(IPC1-7):A61K31/20 主分类号 A61K31/202
代理机构 代理人
主权项
地址